Global Medtech Guidance Tracker: November 2022
Executive Summary
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-eight documents have been posted on the tracker since its last update.
You may also be interested in...
First EU Guidance On Authorized Representative Role And Responsibilities
Manufacturers who are not based in the EU need to have an authorized representative. There is a high level of responsibility, and indeed liability, associated with the function. New guidance explains the rules around the role.
EMA To Explain How Trial Transparency & Data Redaction Can Live Together
The European Medicines Agency is working to align the redaction and data anonymization principles underpinning two EU clinical trial transparency initiatives to ensure consistency in disclosure requirements.
ICH Consults On Modernized GCP Principles To Make Clinical Trials More Efficient
The International Council for Harmonisation has issued updated Good Clinical Practice principles to accommodate new clinical trial and data types.